Skip to main content

Advertisement

Table 5 Adverse events possibly related to BD induction

From: Induction therapy with bortezomib and dexamethasone followed by autologous stem cell transplantation versus autologous stem cell transplantation alone in the treatment of renal AL amyloidosis: a randomized controlled trial

Toxicity Grade 3 Grade 4 Grade 5
Thrombocytopenia, number (%) 8 (28.6%) 1 (3.6%) 0
Neutropenia, number (%) 2 (7.1%) 0 0
Anemia, number (%) 4 (14.3%) 0 0
Gastrointestinal, number (%) 7 (25%) 0 0
Cardiac, number (%) 3 (10.7%) 0 0
Infection, number (%) 8 (28.6%) 0 0
Acute kidney injury, number (%) 2 (7.1%) 0 0
Hepatic, number (%) 3 (10.7%) 0 0
Neuropathy 5 (17.9%) 0 0